Patent Expiry

LNTH: RELISTOR: recorded patent 8956651 expiry

Name: RELISTOR: recorded patent 8956651 expiry
Start: 2031-03-10
End: 2031-03-10

March 10, 2031 · METHYLNALTREXONE BROMIDE. BioSniper AI can trace the company-impact path without requiring you to write the research question.

Event date: March 10, 2031
Company: Lantheus Holdings, Inc. (LNTH)
Drug: METHYLNALTREXONE BROMIDE

BioSniper AIPage evidence connected

Prepared research question

What could this event change, and which evidence should be watched next?

Run cited research

Traceable citations · Unknowns marked

Patent Expiry

RELISTOR: recorded patent 8956651 expiry

March 10, 2031

LNTH overview →

Orange Book application NDA208271, product 001, listed patent 8956651 expiry. Overall loss of exclusivity and current company rights: unknown.FDA source

Company: Lantheus Holdings, Inc. (LNTH)
Drug: METHYLNALTREXONE BROMIDE